Free Trial
→ Trump’s treachery (From Porter & Company) (Ad) Buy NRSN Stock  Free NRSN Stock Alerts

NeuroSense Therapeutics (NRSN) SEC Filings & 10K Form

NeuroSense Therapeutics logo
$2.38 0.00 (0.00%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$2.38 +0.00 (+0.21%)
As of 06/13/2025 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/07/2025
8:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
8:25 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/16/2025
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/11/2025
3:00 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/11/2025
3:00 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/07/2025
4:25 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
8:13 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
01/06/2025
9:40 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
12/12/2024
4:08 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/04/2024
7:32 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
11/22/2024
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
10/31/2024
3:59 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Utah’s New Oil Find (Ad)

The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.

Find out why this could be the most lucrative "underground" energy story in America
07/01/2024
7:05 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/27/2024
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/24/2024
8:20 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:25 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:22 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSN) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Why July 22nd Could Mean Big Changes for Social Security
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...
Altimetry | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Banks aren’t ready for this altcoin—are you?
Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...
Crypto 101 Media | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored